Pfizer Shares Decline

Pepsi Bottling sees volume growing; OfficeMax slips on news of vendor allegations; plus more of Monday's stocks in the news

Pfizer (PFE ) agreed to suspend advertisements for Celebrex, but says it does not plan to recall the drug. Separately, company, Eyetech (EYET ) announced its FDA approval of Macugen for treatment of neovascular (wet) age-related macular degeneration (AMD), eye disease associated with aging that destroys central vision. Shares were lower Monday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.